Latest Breaking News On - Non metastatic castration resistant prostate cancer - Page 1 : comparemela.com

Ulka Nitin Vaishampayan, MBBS, discusses patient factors to consider when choosing between apalutamide, enzalutamide, and darolutamide for the treatment of patients with non-metastatic castration resistant prostate cancer.

United statesUlka nitin vaishampayanPhasei programRogel cancer centerUniversity of michiganOnclive tvNon metastatic castration resistant prostate cancer